NASDAQ: CRME   TSX: COM

VANCOUVER, March 7, 2016 /CNW/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) (“Cardiome” or the “Company”) today announced that it has filed a new prospectus supplement (the “LPC Prospectus Supplement”) pertaining to sales under the…